A review of critical periods for opportunistic infection in the new transplantation era

被引:52
作者
San Juan Garrido, Rafael
Aguado, Jose M.
Diaz-Pedroche, Carmen
Len, Oscar
Montejo, Miguel
Moreno, Asuncion
Gurgui, Mercedes
Torre-Cisneros, Julian
Pareja, Felipe
Segovia, Javier
Garcia, Milagros
Lumbreras, Carlos
机构
[1] Hosp Univ 12 Octubre, Infect Dis Unit, Madrid 28041, Spain
[2] Univ Hosp Valle Hebron, Dept Infect Dis, Barcelona, Spain
[3] Univ Hosp Cruces, Infect Dis Unit, Bilbao, Spain
[4] Univ Barcelona, Hosp Clin Inst Invest Biomed August Pi I Sunyer, IDIBAPS, Dept Infect Dis, E-08007 Barcelona, Spain
[5] Univ Hosp San Pablo, Infect Dis Unit, Barcelona, Spain
[6] Univ Hosp Reina Sofia, Infect Dis Unit, Cordoba, Spain
[7] Univ Hosp Virgen Rocio, Infect Dis Unit, Seville, Spain
[8] Univ Hosp Puerta Hierro, Infect Dis Unit, Barcelona, Spain
关键词
opportunistic infection; transplantation; risk factors;
D O I
10.1097/01.tp.0000245676.43979.86
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background. The risk of opportunistic infection (OI) is considered to be maximum during the first six months after solid organ transplantation. The aim of this study was to know the incidence and risk factors for OI in the late period (> 6 months) compared with the early period (< 6 months) after solid organ transplantation. Methods. We used the online database of the Spanish Network of Infection in Transplantation (RESITRA), which prospectively analyzed 2,702 solid organ transplantation recipients from August 2003 to February 2005. Univariate and multivariate analyses were performed to calculate the risk factors associated with the development of late OI. Results. A total of 131 patients (6%) developed 176 infectious episodes in the late period. Although the incidence of infection and cytomegalovirus disease (0.4 per 1000 transplant days and 0.05 per 1000 transplant days, respectively) was lower than in the early period (3.5 per 1000 transplant days and 0.8 per 1000 transplant days; P < 0.0001), the incidence of other OIs was similar in both periods (0.05 per 1000 transplant days versus 0.03 per 1000 transplant-days, P=0.5). Patients with the higher risk for developing late OI were those receiving early cytomegalovirus prophylaxis, patients who developed two or more episodes of acute rejection during the early period, patients with recurrent bacterial infection during the early period, patients with renal failure requiring dialysis, and patients with chronic graft malfunction. Conclusions. Our data suggest that in some high-risk patients, the critical period of risk for OI must be expanded beyond the first six months after transplant.
引用
收藏
页码:1457 / 1462
页数:6
相关论文
共 20 条
[1]  
ABRADELO M, 2002, 42 INT C ANT AG CHEM, P314
[2]   Clinical presentation and outcome of tuberculosis in kidney, liver, and heart transplant recipients in Spain [J].
Aguado, JM ;
Herrero, JA ;
Gavalda, J ;
TorreCisneros, J ;
Blanes, M ;
Rufi, G ;
Moreno, A ;
Gurgui, M ;
Hayek, M ;
Lumbreras, C ;
Morales, JM ;
Pahissa, A ;
Margerit, C ;
Prada, JL ;
Kindelan, JM ;
Ros, F ;
Pallardo, LM ;
Carratala, J ;
Gudiol, F ;
Gonzalez, J ;
Vilardell, J ;
Guirado, L ;
Rabella, N .
TRANSPLANTATION, 1997, 63 (09) :1278-1286
[3]   Cytomegalovirus disease in high-risk transplant recipients despite ganciclovir or valganciclovir prophylaxis [J].
Akalin, E ;
Sehgal, V ;
Ames, S ;
Hossain, S ;
Daly, L ;
Barbara, M ;
Bromberg, JS .
AMERICAN JOURNAL OF TRANSPLANTATION, 2003, 3 (06) :731-735
[4]   Infection in organ-transplant recipients [J].
Fishman, JA ;
Rubin, RH .
NEW ENGLAND JOURNAL OF MEDICINE, 1998, 338 (24) :1741-1751
[5]   Risk factors for invasive aspergillosis in liver transplant recipients [J].
Fortún, J ;
Martín-Dávila, P ;
Moreno, S ;
de Vicente, E ;
Nuño, J ;
Candelas, A ;
Bárcena, R ;
García, M .
LIVER TRANSPLANTATION, 2002, 8 (11) :1065-1070
[6]   Risk factors for invasive aspergillosis in solid-organ transplant recipients: A case-control study [J].
Gavalda, J ;
Len, O ;
Juan, RS ;
Aguado, JM ;
Fortun, J ;
Lumbreras, C ;
Moreno, A ;
Munoz, P ;
Blanes, M ;
Ramos, A ;
Rufi, G ;
Gurgui, M ;
Torre-Cisneros, J ;
Montejo, M ;
Cuenca-Estrella, M ;
Rodriguez-Tudela, JL ;
Pahissa, A .
CLINICAL INFECTIOUS DISEASES, 2005, 41 (01) :52-59
[7]   Orthotopic liver transplantation in high-risk patients - Risk factors associated with mortality and infectious morbidity [J].
Gayowski, T ;
Marino, IR ;
Singh, N ;
Doyle, H ;
Wagener, M ;
Fung, JJ ;
Starzl, TE .
TRANSPLANTATION, 1998, 65 (04) :499-504
[8]   Initiation of hemodialysis treatment leads to improvement of T-cell activation in patients with end-stage renal disease [J].
Kaul, H ;
Girndt, M ;
Sester, U ;
Sester, M ;
Köhler, H .
AMERICAN JOURNAL OF KIDNEY DISEASES, 2000, 35 (04) :611-616
[9]   Delay of CMV infection in high-risk CMV mismatch lung transplant recipients due to prophylaxis with oral ganciclovir [J].
Palmer, SM ;
Grinnan, DC ;
Reams, BD ;
Steele, MP ;
Messier, RH ;
Davis, RD .
CLINICAL TRANSPLANTATION, 2004, 18 (02) :179-185
[10]   Infections in solid-organ transplant recipients [J].
Patel, R ;
Paya, CV .
CLINICAL MICROBIOLOGY REVIEWS, 1997, 10 (01) :86-+